Dextroamphetamine
- TRADE NAMES: Adderall (Shire); Dexamphetamine; Dexamphetamini; Dexedrine (Alliant); Dextrostat; Ferndex; Mydayis (Shire); Oxydess
- INDICATIONS: Narcolepsy, attention deficit disorder (ADD)
- CLASS: Amphetamine, CNS stimulant
- HALF-LIFE: 10–12 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Fluoxetine, Fluvoxamine, MAO inhibitors, Paroxetine Hydrochloride, Phenelzine, Sertraline, Tranylcypromine
PREGNANCY CATEGORY: C
ABUSE AND DEPENDENCE
See full prescribing information for complete boxed warning.
Please login to see the rest of this drug profile
SKIN.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
NEUROMUSCULAR/SKELETAL.
RESPIRATORY.
OTHER.
Page last updated 07/31/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric